| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964223 | Vaccine | 2015 | 5 Pages |
Abstract
The rubella vaccines used in China that are based on the BRD-II rubella vaccine strain have VE of 94%, which is similar to the more commonly used RA27/3-based RCVs. Low vaccination coverage contributed to this outbreak; early reporting of an outbreak is necessary for effective outbreak response immunization.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Caiyun Chang, Xianghuan Mo, Pei Hu, Wenjia Liang, Huilai Ma, Zhijie An, Jun Liu, Huizhen Zheng,